Q4 2025 earnings call recap: 5% organic growth, bookings +10%, strong free cash flow, and 2026 EPS $10.45–$10.65 guidance—read now.

HANGZHOU, ZHEJIANG, CHINA, January 13, 2026 /EINPresswire.com/ -- In today’s manufacturing climate, efficiency, ...

That 91.1% benefit ratio is harsh. For context, anything above 90% offers very scant opportunities for profitability.

Wall Street analysts remained bullish on Meta, raising their price targets following the tech giant's strong results and ...

Various labour unions and employees' representative bodies have been demanding the revision for years citing rising inflationary pressure and inadequate pension amount under the EPS scheme. At present ...

Joining me today are Stephen Shafer, Chief Executive Officer, and Charles Lauber, Chief Financial Officer. Adjusted earnings, adjusted earnings per share, and adjusted segment earnings exclude the ...

Achieves third quarter revenue growth of 7% as reported and 6% organic, supported by CAG Diagnostics recurring revenue growth of 7% as reported and organic. Organic revenue growth supported by ...

The Indian equity markets have turned largely range-bound after giving up most of their recent gains, amid rising global ...

Achieves first quarter revenue growth of 4% as reported and 5% organic, supported by CAG Diagnostics recurring revenue growth of 3% as reported and 4.5% organic. Organic revenue growth supported by ...

Investing.com -- European infrastructure stocks are poised for significant growth in 2026, with several companies benefiting ...

Retirement is a major milestone in every working person’s life. Along with emotional changes, financial security becomes the ...

As CVS Health has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.